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Objectives. This study sought to assess endothelium-dependent 
vasorelaxation in long-term users of cocaine. 
Background. Cocaine use has been associated with myocardial 
infarction, stroke and intestinal infarction. Previously demon- 
strated effects of the drug, including increased heart rate and 
blood pressure and increased vascular tone, do not explain the 
sporadic nature of these vascular events or the occurrence of 
ischemia remote from acute administration. Abnormal endothe- 
lial function could contribute to focal vasospasm and thrombosis 
and predispose to premature atherosclerosis, all of which have 
been demonstrated in cocaine users with myocardial infarction. 
Methods. Using plethysmography, we studied the change in 
forearm blood flow in response to intraarterial acetylcholine and 
nitroprusside in 10 long-term cocaine users and 13 control 
subjects of similar age who had not used cocaine; sample size was 
based on a 70% power to detect a 20% reduction in flow with 
acetylcholine between subjects and control subjects. Using graded 
doses of intracoronary acetylcholine (from 10 -9 to 10 -6 tool/liter), 
we studied a second group of 10 cocaine users with angiographi- 
cally normal or near-normal arteries. 
Results. Mean forearm blood flow during acetylcholine infusion 
was significantly lower in cocaine users than in control subjects 
(p = 0.02). During nitroprusside infusion, there was no difference 
(p = 0.2) between cocaine users and control subjects. Cigarette 
smoking did not explain the differences between cocaine users and 
control subjects. Acetylcholine licited coronary vasoconstriction 
in 8 of 10 subjects. 
Conclusions. We conclude that endothelium-dependent vasore- 
laxation is impaired in long-term users of cocaine. 
(JAm CoU Cardiol 1996;28:1168-74) 
Although the rate of increase in cocaine abuse in this country 
has slowed, medical problems associated with abuse of the 
drug continue to be a major problem, probably because 
education efforts have had little effect on a core group of 
long-term heavy users. For instance, emergency room visits for 
cocaine-associated chest pain continue to increase. 
It is well established that cocaine can cause catastrophic 
vascular events, including myocardial infarction (l-7), stroke 
(8,9) and intestinal infarction (10). Cocaine causes an increase 
in heart rate and blood pressure at acute administration (11), 
resulting from systemic atecholamine r lease and increased 
alpha-adrenergic effects due to blockade of norepinephrine 
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reuptake. However, these phenomena cannot explain all the 
observed vascular events. Other drugs that inhibit norepineph- 
rine reuptake, such as tricyclic antidepressants, are not associ- 
ated with vascular catastrophes. The vast majority of cocaine 
administrations do not result in a vascular event, and the 
majority of myocardial ischemic events associated with cocaine 
use occur long after acute administration (12). Cocaine in- 
creases vascular tone because of its enhancement of alpha- 
adrenergic effects (13) and calcium influx into vascular smooth 
muscle (14). However, a diffuse increase in vascular tone does 
not explain the focal vasospasm that causes infarction. Cocaine 
appears to cause premature atherosclerosis (15,16), but 
cocaine-related infarction can occur in the absence of athero- 
sclerosis. Vascular endothelium exerts control over local blood 
flow in many ways, including inhibition of thrombosis and 
release of vasodilating and vasoconstricting substances (17). 
Nitric oxide is released from the endothelium in response to a 
multitude of stimuli, including exposure to acetylcholine, and 
causes relaxation of underlying smooth muscle and inhibition 
of platelet aggregation. Impairment of this release may con- 
tribute to vasospasm and thrombosis. Dysfunction of the 
endothelium, in addition, is thought to be an essential step for 
initiating the process of atherosclerosis (18). Damage to vas- 
cular endothelium in long-term cocaine users would impair 
nitric oxide release, which in turn might contribute to vaso- 
spasm and thrombosis and the initiation of atherosclerosis. 
We hypothesized that endothelium-dependent vasorelax- 
© 1996 by the Amcrican College of Cardi~logy 0735-1097/96/$15.00 
Published by Elsevier Science Inc. PIt S0735-1097(96)00299-9 
JACC Vol. 28, No. 5 HAVRANEK ET AL. 1169 
November 1, 1996:1168-74 COCAINE ARTERIOPATHY 
ation is impaired in long-term cocaine users. Measures of 
endothelial function in humans exposed to long-term cocaine 
use have not been reported. 
Methods 
Study subjects. All subjects gave written informed consent. 
The protocol was approved by our institutional review boards. 
Patients were included if they gave a history of having used 
cocaine for at least 6 months before enrollment and were 
excluded for a history of hypertension, hyperlipidemia (serum 
cholesterol >5.53 mmol/liter [220 mg/dl] or low density 
lipoprotein-cholesterol >4.53 retool/liter [180 mg/dl]) or dia- 
betes or current vasodilator use. Control subjects had no 
history of cocaine use within 1 year of the study and no history 
of hypertension, diabetes, hyperlipidemia or current vasodila- 
tor use. 
We studied 10 cocaine users by forearm plethysmography. 
Seven of the 10 had urine test results positive for cocaine 
metabolites within 1 week of the study. Two had a previous 
myocardial infarction; coronary angiographic findings were 
normal in one and showed obstructive coronary disease in the 
other. Of the remaining eight patients, ix had presented with 
chest pain. Coronary angiography was performed in five of 
these six patients; four had normal coronary arteries, and one 
had nonobstructive disease. One patient had a reduced left 
ventricular ejection fraction thought o be consistent with 
cocaine-related cardiomyopathy but did not have congestive 
heart failure. The control group consisted of 13 healthy 
volunteers. 
We studied 10 cocaine users during coronary arteriography 
for evaluation of cocaine-related chest pain (n = 8), dyspnea 
(n = 1) or an atrial septal defect (n = 1). Nine of 10 patients 
had a history of cocaine use within 3 weeks of the study. Two 
had a previous myocardial infarction. Angiographic findings 
were normal in eight patients and showed nonobstructive 
disease in the infarct-related artery in two; their adjacent 
arteries were normal. Clinical characteristics of the study 
cohort are presented in Table 1. 
Protocol. Forearm plethysmography. The technique of 
forearm plethysmography as been previously described 
(19,20). A 20-gauge catheter was inserted into the brachial 
artery before each study. Subjects were allowed to relax in a 
supine position with the arm elevated above the level of the 
midatrium to facilitate venous return from the limb. Room 
temperature was controlled at 72°F. A blood pressure cuff was 
inflated at the wrist to suprasystolic pressures to exclude the 
highly variable flow to the hand, and another cuff was inflated 
over the arm with a rapid inflator to less than diastolic pressure 
(-40 mm Hg) to prevent venous return from the forearm. 
Blood flow is proportional to the change in diameter of the 
widest part of the forearm, as measured by a mercury-filled 
Silastic strain gauge attached to a plethysmograph (Hokanson 
ECR). Once stable baseline flow rates were established uring 
dextrose infusion, acetylcholine (7.5, 15 and 30 /zg/min) and 
nitroprusside (0.3, 3 and 10/xg/min) were infused through the 
Table l. Demographics of Study Cohort 
Plethysmography 
Angiography: 
Cocaine Control Cocaine 
Uscrs Subjects Users 
(n = 10) (n - 13) (n = 10) 
Age (yr) 38.6 0+ 3.4 31.3 _+ 6.6 36.5 -+ 5.1 
Male/female 8/2 7/6 10/0 
Ethnicity (white/black/Hispanic) 6/'3/1 11/1/1 0/9/1 
Current smoking 10/10 7/13 9/10 
Blood pressure (ram Hg) 
Systolic 126 ± 14 113 + 9 123 -+ 27 
Diastolic 77 + 9 73 _+ 6 78 -+ 17 
Data presented are mean value _+ SD or number of patients. 
arterial catheter for 3 min at each dose. The order of drug 
administration was varied randomly. The flow rate was held 
constant for baseline and drug infusions. At the conclusion of 
each 3-rain infusion, five measurements were made; flow was 
considered to be the average of these measurements. Strip- 
chart records were interpreted without knowledge of the drug 
or dosage involved. 
Coronary arteriography. A 6F bipolar pacing catheter was 
placed in the right ventricle for demand pacing. An 8F 
large-lumen angioplasty guide catheter was advanced to the 
ostium of the left coronary artery using the Judkins technique. 
A screening, selective coronary angiogram of the left main 
coronary artery was then obtained to exclude significant coro- 
nary artery disease. A 2.5F infusion catheter was advanced 
within the guide catheter to the ostium on the left main 
coronary artery. This position allowed continuous infusion of 
acetylcholine during coronary angiography. After each infu- 
sion (vehicle, graded oses of acetylcholine or nitroglycerin), 
biplane coronary angiography was performed. 
Serial 3- to 4-rain infusions of vehicle (5% dextrose in water 
plus 0.005% mannitol) and graded concentrations of acetyl- 
choline (to achieve stimated final blood concentrations i  the 
coronary bed of 10 9, 10 8 and 10 7 tool/liter) were given, 
followed after the last infusion by a bolus of 150 to 200 pg of 
intracoronary nitroglycerin. The final coronary blood concen- 
trations of acetylcholine were estimated with the assumption 
that blood flow in the left main coronary artery is -120 ml/min. 
Biplane images of the coronary arteries were obtained with 
a standard cineangiographic system (Philips Optimus M-200 
Generator and Poly-C, Eindhoven, The Netherlands). Non- 
ionic contrast (Iohexol, Winthrop-Breon Laboratories) was 
used for each injection. A standard injection profile (4 ml/s for 
9 ml) was power injected (Medrad). Optimal visualization in 
the right anterior oblique projection with caudal angulation 
and the left lateral projection with no or minimal angulation 
was obtained to maximize vessel separation. These projections 
were maintained throughout the study for each patient with 
care to maintain image intensifier and table position constant. 
Coronary arteriograms were analyzed using the cardiovas- 
cular angiographic analysis ystem and previously described 
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Figure 1. Forearm blood flow at increas- 
ing doses of nitroprusside (Npr) for co- 
caine users and control subjects. *Mann- 
Whitney rank-sum test. By analysis of 
variance for repeated measures, there is 
no difference in flow (p = 0.2). 
methods (21). All angiograms were qualitatively interpreted by 
two unblinded independent observers (P.A.G., EJ.E.). 
One proximal region of interest in the left anterior descend- 
ing coronary artery was selected in each patient for analysis. A 
region was selected for ease of assessment and lack of over- 
lapping branches. These same regions were analyzed after each 
intervention, using an end-diastolic frame. 
The standard eviation for the difference between repeat 
measurements of the same lesion using the cardiovascular 
angiographic analysis system was 0.12 to 0.16 (21). Thus, we 
defined a significant change in vessel size as a >0.25-ram (>2 
SD) change in diameter. 
Statistical analysis. Comparisons of changes in forearm 
blood flow between cocaine users and normal control subjects 
were performed with the Mann-Whitney rank sum test. To 
confirm these results, and to study the dose effects of acetyl- 
choline and nitroprusside on blood flow, a two-way repeated 
measures analysis of variance was performed. Because data did 
not conform to a normal distribution, log-transformed values 
were used. Sample size was based on a 70% power to detect a 
20% reduction in flow with acetylcholine between cocaine 
users and control subjects. The coronary angiographic data 
were analyzed with a repeated measures analysis of variance. 
All results are expressed as mean value _+ SD, unless otherwise 
stated. All analyses were computed using the BMDP statistical 
software. Significance was defined as p <- 0.05. 
Results  
Forearm blood flow. In cocaine users, blood flow at base- 
line was 3.5 _+ 0.8 ml/100 cm 3 forearm tissue per min, increased 
to a maximum of 12.8 _+ 4.1 ml/100 cm 3 forearm tissue per rain 
with nitroprusside and to a maximum of 6.1 _+ 4.1 ml/100 cm 3 
forearm tissue per rain with acetylcholine. In control subjects, 
blood flow at baseline was 3.6 _ 0.9 ml/100 cm 3 forearm tissue 
per rain, increased to a maximum of 18.4 _+ 5.6 ml/100 cm 3 
forearm tissue per rain with nitroprusside and to a maximum of 
10.3 _+ 7.4 ml/100 cm 3 forearm tissue per rain with acetylcho- 
line. 
Forearm blood flows at increasing nitroprusside doses are 
shown in Figure 1. By analysis of variance for repeated 
measures, there was no difference between cocaine users and 
control subjects (p = 0.2) with nitroprusside. The test for 
interaction effects was not significant (p = 0.20). By Mann- 
Whitney analysis, there were no significant differences in blood 
flow at any dose tested, 
Forearm blood flows at increasing acetylcholine doses are 
shown in Figure 2. The difference in flow between cocaine 
users and control subjects was significant by analysis of vari- 
ance for repeated measures, with control subjects having 
greater flow (p = 0.02). The test for interaction effects was not 
significant (p = 0.09). There were significant differences by 
Mann-Whitney testing at the first two but not the highest dose 
that was tested. 
Because all 10 cocaine users and 7 of 13 control subjects 
were smokers, we used analysis of variance to test for the 
possibility that smoking alone was responsible for the differ- 
ences in blood flow between users and control subjects. Results 
are shown in Table 2. There were no significant differences in 
blood flow between cocaine users and control subjects who did 
and did not smoke. 
Coronary angiography. No patient developed severe bra- 
dycardia from the infusion of acetylcholine, although a pro- 
phylactic pacemaker was in place for each patient. Figure 3 is 
shows a representative example of vasoconstriction f the left 
anterior descending and left circumflex coronary arteries after 
intracoronary acetylcholine administration i  a subject with 
angiographically normal coronary arteries. As is evident from 
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Figure 2. Forearm blood flow at increas- 
ing doses of acetylcholine (Ach) for co- 
caine users and control subjects. *Mann- 
Whitney rank-sum test. By analysis of 
variance for repeated measures, there is 
significant difference in flow (p - 0.02). 
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Figure 4, 2 of the 10 patients had normal vasodilator responses 
to acetylcholine, whereas 8 (80%) of these 10 demonstrated 
coronary artery vasoconstriction. This effect was subsequently 
abolished by the administration f intracoronary nitroglycerin. 
Seven of the 10 cocaine users demonstrated coronary artery 
vasodilation beyond baseline values with the administration f 
intracoronary nitroglycerin, thereby demonstrating the ability 
of the artery to vasodilate to endothelium-independent vaso- 
dilators. 
Discuss ion  
Previous tudies of cocaine-induced ischemic heart disease 
in patients have focused on the pharmacologic properties of 
cocaine that promote vasoconstriction or thrombosis. Such 
studies have not explained why myocardial ischemic events are 
often seen days after cocaine ingestion (12). Our results how 
that long-term cocaine users have impaired endothelium- 
dependent vasorelaxation i both small-caliber forearm resis- 
tance vessels and large-caliber epicardial vessels. 
Relation between endothelial dysfunction and ischemic 
events in cocaine users. These data provide a new and attrac- 
tive hypothesis to explain the temporal disparity between 
cocaine use and ischemic events. Cocaine has three indepen- 
dent mechanisms of vasoconstrictive action: 1) There is direct 
vasoconstriction, which is calcium channel dependent (14) and 
endothelium independent (22). 2) There is indirect vasocon- 
striction, which is mediated through norepinephrine release by 
the sympathetic nervous ystem and alpha-receptors (13). 3) 
There is vasoconstriction as a consequence of platelet, white 
blood cell or endothelium-derived mediator release, alone or 
in combination, which promotes vasoconstriction (23). We 
propose that dysfunctional endothelium is an additional route 
that links cocaine to ischemic events. 
Dysfunctional endothelium in cocaine users may participate 
in the genesis of ischemic vascular accidents in one of three 
ways: 1) Dysfunctional endothelium ay contribute to a milieu 
conducive to thrombosis either at the time of cocaine use or at 
a time remote from use. Nitric oxide inhibits platelet aggrega- 
tion (24,25); impairment of nitric oxide release from the 
endothelium would fail to counterbalance the effects of plate- 
let aggregation. In addition, the ratio of thromboxane B2 to 
6-keto-prostaglandin Fz-alpha has been shown to be increased 
in a rabbit model of short-term cocaine administration (26). 
This finding suggests hat cocaine produces changes in prosta- 
glandin metabolism favoring vasoconstriction a d thrombosis. 
Table 2. Effect of Smoking on Blood Flow* 
Acetycholine (~g/min) Nitroprusside (txg/min) 
Baseline 7.5 15 30 0.3 3 10 
Cocaine user 3.5 = (I.8 3.4 _+ 0.7 4.6 ± 2.6 6.1 + 4.3 5.4 ~+ 1.5 10.0 _+ 2.9 12.8 z 4.4 
Control subject 
Nonsmoker 4.0 + 0.9 4.9 _+ 1.4 6.1 -+ 2.6 8.7 _+ 3.9 5.9 -+ 1.6 11.3 _+ 4.3 15.3 + 5.9 
Smoker 3.2 + 0.8 5.1 ± 1.1 6.5 ± 4.3 11.7 + 10.3 6.2 ~+ 1.4 14.0 _+ 4.5 20.7 -+ 6.7 
p value (within doses) 0.2 0.f19 
*Values presented are mean forearm blood flow in ml/100 cm 3 tissue per min _+ SD. 
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Figure 3. Representative angiograms showing vaso- 
constriction of the left anterior descending and left 
circumflex coronary arteries after intracoronary acetyl- 
choline administration i a subject with angiographi- 
cally normal coronary arteries. Top, Right anterior 
oblique view of the left coronary artery system before 
administration facetylcholine (during administration 
of control vehicle). Bottom, Same projection of the left 
coronary artery system after administration of acetyl- 
choline. Constriction was more pronounced in the left 
anterior descending than in the circumflex coronary 
artery in this case, 
Figure 4. Individual responses of the left anterior descending coronary 
artery to acetylcholine (ACh). Note that two of the patients howed 
vasodilation, whereas eight demonstrated vasoconstriction. NTG 
nitroglycerin. 
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2) Premature atherosclerosis i  present in some long-term 
cocaine users. If impairment of endothelium-dependent r lax- 
ation in cocaine abusers is a marker for repetitive ndothelial 
damage, the necessary first step in the atherosclerotic process 
(27) has been established. 3) A relative deficiency of vasodi- 
lating factors uch nitric oxide and an increase in vasoconstrict- 
ing factors such as thromboxane A2, serotonin and endothelin 
may predispose to vasoconstriction a d vasospasm. There is 
substantial evidence from published reports to support the 
latter mechanism (28). 
Previous studies. Flores et al. (29) administered intranasal 
cocaine to 12 patients undergoing coronary angiography for 
evaluation of chest pain; apparently none had been exposed to 
long-term cocaine use. Quantitative analysis of coronary lumen 
diameter was performed before and after cocaine administra- 
tion. Percent reduction in lumen diameter was greater in 
diseased than nondiseased segments. Flores et al. hypothesized 
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that this effect was the result of lack of nitric oxide as a 
counterbalance for cocaine-mediated alpha-adrenergic vaso- 
constriction. 
Egashira et al. (30) provided support for this hypothesis n 
a study in a miniature swine model. Eight pigs underwent 
endothelial denudation i the left anterior descending coro- 
nary artery followed by 3 months of high cholesterol feeding. 
Intravenous cocaine was then administered in increasing doses, 
and the coronary lumen diameter was compared in previously 
denuded and nondenuded sites by means of angiography. No 
lumen narrowing was apparent at baseline in either site. After 
higher doses of cocaine, lumen diameter diminished more at 
previously denuded sites than at nondenuded sites. Further- 
more, they observed vasospasm in all pigs after intracoronary 
histamine at the previously denuded sites. 
Kuhn et al. (22) provide somewhat conflicting results. Using 
seven dogs, they administered cocaine immediately after en- 
dothelial denudation i the left anterior descending coronary 
artery. Angiographically, they were unable to show enhanced 
vasoconstriction at the denuded site. Explanations for the 
discrepancy include the lower dose of cocaine used by Kuhn et 
al. (2 vs. 10 mg/kg) and the difference in time between 
intervention and study. It may be that the myointimal prolif- 
eration observed by Egashira et al. (30) is crucial for potenti- 
ation of cocaine-induced vasoconstriction. 
Our results differ somewhat from those of Halle et al. (31). 
These investigators tudied seven subjects who had had 
cocaine-related chest pain using forearm plethysmography at 
baseline, after a cold pressor test, and after 10 min of forearm 
ischemia. They found no differences between cocaine users 
and control subjects in forearm blood flow for any of the 
conditions studied. If forearm flow after ischemia is taken as a 
measure of flow-mediated, endothelium-dependent vasorelax- 
ation, the study of Halle et al. is evidence that cocaine use is 
not associated with impairment of endothelium-dependent 
vasorelaxation. It may be that the reactive hyperemia test was 
not sufficiently sensitive to detect endothelial dysfunction i
their relatively small group of subjects. Another possible 
explanation is that the endothelial dysfunction induced by 
cocaine is not generalized but is limited to muscarinic-receptor 
and like pathways. 
Effect of smoking. By forearm plethysmography, blood 
flow response was significantly less in cocaine users than in 
control subjects with acetylcholine. Smoking does not explain 
this impairment. If smoking were responsible for the impaired 
response to acetylcholine incocaine users, we should have seen 
a difference within doses for acetylcholine, with nonsmoking 
control subjects having a greater esponse and cocaine users 
having essentially the same response as smoking control sub- 
jects. In the coronary arteries, 8 of 10 patients had coronary 
artery vasoconstriction i response to acetylcholine adminis- 
tration. Two of these ight had frank vasospasm and chest pain 
that reproduced previous symptoms. Because patients with 
normally functioning endothelium exhibit vasodilation in re- 
sponse to acetylcholine, this effect clearly represents an abnor- 
mal response (32). 
It is not clear from previous tudies whether smoking causes 
an abnormality in the phenomenon that we studied-- 
differential change in blood flow in response to acetylcholine 
and nitroprusside or nitroglycerin. Two studies have investi- 
gated the effects of smoking on the response of coronary 
arteries to acetylcholine: One (32) found no difference in 
response between smokers and nonsmokers, and the other (33) 
showed iminished responsiveness in smokers. Using different 
methodology, Celermajer et al. (34,35) measured the diameter 
of the brachial artery in smokers and normal control subjects in 
response to ischemia nd to nitroglycerin. These investigators 
found that the increase in diameter in response to ischemia 
was smaller in smokers than control subjects, but the response 
to nitroglycerin was no different. Estimated blood flow in 
response to ischemia was not different between smokers and 
control subjects. Similarly, our data are not consistent with 
differences in endothelium-mediated flow response between 
smokers and nonsmokers. 
Possible mechanisms for cocaine-related endothelial dys- 
function. The mechanism for the impairment ofendothelium- 
dependent vasorelaxation is unclear. The most likely explana- 
tion is that of a direct toxic effect of cocaine on endothelial 
cells. In animals, repetitive exposure to cocaine has been 
reported (26) to cause endothelial proliferation, presumably 
an indicator of endothelial cell turnover. In porcine coronary 
arteries, regenerating endothelium shows a lack of responsive- 
ness to some nitric oxide-releasing factors for up to 24 weeks 
after denudation (36). If cocaine is indeed toxic to vascular 
endothelium, repeated cycles of cell loss and regeneration may 
render the endothelium unable to respond to G protein- 
mediated releasing agents for nitric oxide, such as acetylcho- 
line. 
In a system as complex as that of control of vascular tone, 
there are many other ways in which cocaine might impair 
endothelium-dependent vasorelaxation. Several endothelium- 
derived contracting factors such as endothelin have been 
described; cocaine may enhance their activity. The physiologic 
importance of endothelium-derived contracting factors is as 
yet poorly established, although endothelin probably is respon- 
sible in part for maintaining basal arterial tone (37). Acetyl- 
choline causes contraction of smooth muscle; long-term co- 
caine exposure might enhance the sensitivity of that tissue to 
muscarinic stimulation. In support of this notion, Shannon et 
al. (38) demonstrated that atropine attenuates the increase in 
coronary vascular esistance brought about by the acute ad- 
ministration of cocaine. This demonstration f an acute para- 
sympatholytic effect of cocaine raises the possibility that long- 
term antagonist exposure may enhance sensitivity to 
muscarinic stimulation. Similarly, long-term stimulation of the 
sympathetic nervous system or long-term repeated agonistic 
catecholamine exposure caused by cocaine might downregu- 
late the endothelium-dependent r laxation system; however, 
data on autonomic control of nitric oxide synthesis and release 
are conflicting (39,40). 
Limitations of the study. There are several limitations to 
the present study: 1) The cocaine users studied were a selected 
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group, in that most of them had presented with chest pain. 2) 
Some may view the use of the forearm model as a limitation. 
However, because cocaine has produced vascular events in 
multiple organ systems, we postulated a generalized vascular 
disorder related to cocaine abuse and believed the forearm 
model to be relevant. 3) We did not include a group of healthy 
matched control subjects for comparison of coronary arterio- 
graphic data. We strongly believe that exposing a group of 
subjects without chest pain or suspicion of coronary disease to 
the risks of angiography is not justifiable, especially in light of 
the data acquired in the forearm portion of the study. 
Conclusions. Endothelium-dependent vasorelaxation is 
impaired in long-term users of cocaine; this impairment may 
contribute to the genesis of vascular events in this patient 
group. 
This study would not have been possible without the technical assistance of 
Melvin Harris, RN. 
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